辉瑞制药（Pfizer）2021年环境、社会和治理（ESG）报告（英文版）

Environmental, Social& Governance ReportPfizer 2021Pfizer 2021 ESG Report2In This ReportIntroductionA letter from our Chairman & CEOA letter from our Lead Independent DirectorProgress and highlights 2021Our approach to ESGPriority ESG issuesImpact StoriesMoving at the Speed of Science to Address a Global CrisisFinancing for a Sustainable FutureRefreshing Our DEI StrategyEnvironmentClimate ChangeSustainable MedicinesSocialInnovation and Global HealthHuman CapitalGovernanceEthics, Transparency, and QualityAccountabilityPerformanceEnvironmentSocialGovernanceAppendixGRI indexSASB indexTCFDAbout This ReportIndependent Accountants’ Report0304080910121415182325262931323740414951525561626373768182This report provides information on our ESG progress in the year from January 1, 2021, to December 31, 2021; it includes an overview of performance, as well as data on 32 key performance indicators. For more information please see About this Report on page 81.Where to find more informationWhat this re